Clinical Trials Directory

Trials / Unknown

UnknownNCT02001285

Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Double-lumen Endobronchial Intubation

Comparison of the Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Ordinary Tracheal and Double-lumen Endobronchial Intubation During Propofol-remifentanil Total Intravenous Anesthesia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Jeju National University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is the comparison of the effect-site concentration of remifentanil for blunting hemodynamic responses to ordinary tracheal and double-lumen endobronchial intubation during propofol-remifentanil total intravenous anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGRemifentanilDuring intubation, remifentanil will be infused to prevent change arterial blood pressure and heart rate.

Timeline

Start date
2013-10-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2013-12-04
Last updated
2013-12-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02001285. Inclusion in this directory is not an endorsement.

Effect-site Concentration of Remifentanil for Blunting Hemodynamic Responses to Double-lumen Endobronchial Intubation (NCT02001285) · Clinical Trials Directory